NCT04467411 (EMBRACE) is a clinical trial in Breast Cancer, sponsored by University of Aberdeen.

Who is sponsoring NCT04467411?

NCT04467411 is sponsored by University of Aberdeen.

What condition does NCT04467411 study?

NCT04467411 studies Breast Cancer.

Is NCT04467411 still recruiting?

NCT04467411 is currently recruiting now. Last updated 24 December 2024.

Last reviewed 2024-12-24 · How we verify

NCT04467411: EMBRACE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The EMBRACE Study The EMBRACE Study

Recruiting now Last updated 24 December 2024

What this trial tests

trial in Breast Cancer in 70 participants. Currently enrolling.

Timeline

1 February 2020

Primary endpoint
30 August 2030

30 August 2030

Quick facts

Lead sponsor	University of Aberdeen
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	70
Start date	1 February 2020
Primary completion	30 August 2030
Estimated completion	30 August 2030
Sites	1 location across United Kingdom

Conditions studied

Breast Cancer — all drugs for Breast Cancer →

Sponsor

University of Aberdeen

Who can join

18 and older, female only, with Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cardiomyopathy is a condition that affects the heart muscle, whereby it becomes enlarged, thick or rigid. When the heart muscle becomes involved, it affects the pumping action of the heart. This condition can affect as many as 10% of all patients after undergoing anthracycline cancer drug therapy and unfortunately carries the worst prognosis of all cardiomyopathies. To date, there is no effective intervention that will prevent a patient from developing this condition. The research conducted will look to see if an energy imbalance in the heart predates the onset of detrimental changes to the pumping function of the heart, if this is detected then we can act earlier to prevent the pumping function deteriorating.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Physical Activity as an Imperative Support in Breast Cancer Management.
Ortega MA, Fraile-Martínez O, García-Montero C, Pekarek L, et al · · 2020 · cited 34× · PMID 33379177 · DOI 10.3390/cancers13010055
Impaired Cardiac and Skeletal Muscle Energetics Following Anthracycline Therapy for Breast Cancer.
Gamble DT, Ross J, Khan H, Unger A, et al · · 2023 · cited 7× · PMID 37847761 · DOI 10.1161/circimaging.123.015782
Comparison of Definitive Cervical Cancer Management With Chemotherapy and Radiation Between Two Centers With Variable Resources and Opportunities for Improved Treatment.
Asamoah FA, Yarney J, Scott A, Vanderpuye V, et al · · 2020 · cited 5× · PMID 33021855 · DOI 10.1200/go.20.00303

Verify or expand the search:

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting

Other University of Aberdeen trials

Trials by the same sponsor.

NCT07070765 — Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity · NA · not yet recruiting
NCT07065383 — Rebalancing the Fat Content of the Heart and Muscles · NA · recruiting
NCT06735573 — Protein, Sarcopenic Obesity, and COPD · not yet recruiting
NCT06714656 — Drivers and Barriers for Adopting Healthy and Sustainable Food Swaps in Young · NA · recruiting
NCT06721312 — Continuous Heart Rate Variability Monitoring in Doctors; Understanding Patterns of Stress and Recovery and Their Relatio · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04467411 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Aberdeen
Last refreshed: 24 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04467411.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing